Read More

Coupang Inc: Entered Repurchase Agreement, Effective As Of April 1, With Maverick Holdings C, L.P. For The Co To Repurchase 10M Shares Of The Company’s Class A Common Stock For $17.79 Per Share In A Privately Negotiated Transaction For An Aggregate Pur…

- SEC Filing On April 2, 2024, Coupang, Inc. (the "Company") entered into a Share Repurchase Agreement (the "Repurchase Agreement"), which is effective as of April 1, 2024, with Maverick Holdings C, L.P., an early

CPNG

Read More

Dr. Reddy’s Laboratories Ltd. And Bayer Entered Into A Partnership To Market And Distribute A Second Brand Of Vericiguat In India. Under The Terms Of This Agreement, Bayer Has Granted Non-Exclusive Rights To Dr. Reddy’s Under The Brand Name Gantra

- SEC Filing Dr. Reddy's Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE:RDY, NSEIFSC: DRREDDY, hereafter referred to as "Dr. Reddy's")) and Bayer announced that both companies have entered into a partnership to

RDY